GH Research PLC (GHRS)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $18.75
- As of
Kresmion compiles this page from GHRS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
GH Research PLC (GHRS): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-13.
See the full GHRS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GHRS on one page. Preview it with sample data, then open it live with a free account.
Preview the GHRS dossierActive events for GHRS
- high13F: large increase
CITADEL ADVISORS LLC added +227% to GHRS (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 66% of GHRS (2026Q2)
- medium13F: new position
D. E. Shaw & Co., Inc. new position in GHRS
- mediumEarnings above estimates
Q2-2026: Beat consensus by 25.6%, EPS $-0.23 vs $-0.3091 estimate
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +217% to GHRS (2026Q1)
FREE, NO ACCOUNT
Every event on GHRS, as it fires
You are seeing 5 of 10 events recorded on GHRS since 2026-06-18.
The five above landed across 3 days. The other 5 were recorded on 2 other days. 5 of the 10 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, GHRS
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
More data on GHRS
GHRS against its peers
GHRS's return on equity of -17.3% ranks in the 84th percentile of 15 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.
| Metric | GHRS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 67.7M | n/a | 11 |
| Gross margin | n/a | 92.3% | n/a | 5 |
| Operating margin | n/a | -239.8% | n/a | 11 |
| Net margin | n/a | -170.1% | n/a | 11 |
| Return on equity | -17.3% | -46.3% | 84 | 15 |
| 1 year | 30.4% | 13.1% | 63 | 19 |
Peers (20): INBX, ABSI, MNKD, TSHA, SLN, URGN, DMRA, LBRX, MLYS, NTLA, VOR, KRSA, ANAB, NVAX, CMPS, IMCR, DRTS, TYRA, MLTX, RAPP. Left out: AAPG (period gap), AVLN (no annual filing), KALV.D (no annual filing), KARD (no annual filing), ADRX (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (GHRS: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in GHRS on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on GHRS in the last 180 days.
Upstream: SEC EDGAR filings for GHRS
Kresmion, "GH Research PLC (GHRS) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/GHRS. Upstream data: SEC EDGAR filings for GHRS.
Link to this data (HTML):
<a href="https://kresmion.com/research/GHRS">GH Research PLC (GHRS) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow GHRS on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to GHRS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.